InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
3
Disclosed sells
0
T+90 hit rate
75%
T+90 mean return
+32.6%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by BOLL ANDREW R., Chief Financial Officer. Insider active across 5 companies, notably HARROW, INC.. Cumulatively, 11 filings have been recorded. Breakdown: 3 buys · 0 sell. Total volume traded: €211k. Activity tracked since 22 December 2022. The latest transaction was disclosed on 14 May 2026 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations11 total
3,500 shares@ US$29.900.0077% mcap50.1% of flowCommon StockSEC:0001493152-26-023319:0
Ideal exit: 8 Feb 2027 (T+270)
3,500 shares@ US$29.76230.0077% mcap49.9% of flowCommon StockSEC:0001493152-26-023319
Ideal exit: 8 Feb 2027 (T+270)
346,500 shares0Common StockSEC:0001641172-25-003112:0
45,000 shares@ US$10.6765.8% of flowCommon stockSEC:0001493152-24-007454:0
7,400 shares@ US$7.717.8% of flowCommon stockSEC:0001493152-24-005370:0
346,500 sharesCommon StockSEC:0001493152-23-025146:0
90,000 shares@ US$6.0093.9% of flowCommon StockSEC:0001493152-23-010882:0
23,000 sharesCommon StockSEC:0001493152-23-000191:0
2,500 shares@ US$13.546.1% of flowCommon StockSEC:0001493152-22-036395:0
Ideal exit: 18 Sept 2023 (T+270)
50,000 sharesCommon StockSEC:0001493152-22-005271:0
15,000 sharesCommon StockSEC:0001493152-16-007108:0
11 of 11 declarations
About BOLL ANDREW R.
Andrew R. Boll is the President and Chief Financial Officer at Harrow, Inc. and Harrow Health, Inc. He is responsible for financial management and strategy for the company. Boll plays a key role in optimizing financial processes and implementing strategies aimed at improving Harrow's financial performance.
